{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T08:11:01Z","timestamp":1778487061982,"version":"3.51.4"},"reference-count":167,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"DOI":"10.1007\/s11926-026-01219-x","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T08:13:27Z","timestamp":1776240807000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Myositis Mimics: Recognizing Red Flags and Diagnostic Pitfalls"],"prefix":"10.1007","volume":"28","author":[{"given":"Bhaskar","family":"Roy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Latika","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teerin","family":"Liewluck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"issue":"5","key":"1219_CR1","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1212\/cont.0000000000001611","volume":"31","author":"M Milone","year":"2025","unstructured":"Milone M. A pattern recognition approach to myopathy. Continuum (Minneap Minn). 2025;31(5):1244\u201369. . https:\/\/doi.org\/10.1212\/cont.0000000000001611","journal-title":"Continuum (Minneap Minn)"},{"issue":"9","key":"1219_CR2","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S1474-4422(25)00233-9","volume":"24","author":"J Raaphorst","year":"2025","unstructured":"Raaphorst J, van der Kooi AJ, Mecoli CA, et al. Advances in the classification and management of idiopathic inflammatory myopathies. Lancet Neurol Sep. 2025;24(9):776\u201388. https:\/\/doi.org\/10.1016\/S1474-4422(25)00233-9.","journal-title":"Lancet Neurol Sep"},{"issue":"1","key":"1219_CR3","doi-asserted-by":"publisher","first-page":"e209496","DOI":"10.1212\/WNL.0000000000209496","volume":"9","author":"S Shelly","year":"2024","unstructured":"Shelly S, Soontrapa P, Madigan NN, et al. Compound Muscle Action Potential and Myosin-Loss Pathology in Patients With Critical Illness Myopathy: Correlation and Prognostication. Neurology Jul. 2024;9(1):e209496. https:\/\/doi.org\/10.1212\/WNL.0000000000209496.","journal-title":"Neurology Jul"},{"issue":"7","key":"1219_CR4","doi-asserted-by":"publisher","first-page":"e214101","DOI":"10.1212\/WNL.0000000000214101","volume":"7","author":"P Soontrapa","year":"2025","unstructured":"Soontrapa P, Jones FJS, Milone M, et al. Clinicopathologic Features, Pathogenesis, and Treatment of Monoclonal Gammopathy-Associated Myopathies. Neurology Oct. 2025;7(7):e214101. https:\/\/doi.org\/10.1212\/WNL.0000000000214101.","journal-title":"Neurology Oct"},{"key":"1219_CR5","doi-asserted-by":"publisher","first-page":"105363","DOI":"10.1016\/j.nmd.2025.105363","volume":"50","author":"MP Skolka","year":"2025","unstructured":"Skolka MP, Pinal-Fernandez I, Mammen AL, Liewluck T. Emerging atypical clinicopathological manifestations of immune-mediated necrotizing myopathy (IMNM). Neuromuscul Disord May. 2025;50:105363. https:\/\/doi.org\/10.1016\/j.nmd.2025.105363.","journal-title":"Neuromuscul Disord May"},{"issue":"12","key":"1219_CR6","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tjarnlund A, Bottai M, et al. 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis Dec. 2017;76(12):1955\u201364. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211468.","journal-title":"Ann Rheum Dis Dec"},{"issue":"1","key":"1219_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11926-024-01171-8","volume":"5","author":"GR Harvey","year":"2024","unstructured":"Harvey GR, MacFadyen C, Tansley SL. Newer Autoantibodies and Laboratory Assessments in Myositis. Curr Rheumatol Rep Dec. 2024;5(1):5. https:\/\/doi.org\/10.1007\/s11926-024-01171-8.","journal-title":"Curr Rheumatol Rep Dec"},{"issue":"1","key":"1219_CR8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41584-024-01188-4","volume":"21","author":"NA Allameen","year":"2025","unstructured":"Allameen NA, Ramos-Lisbona AI, Wedderburn LR, Lundberg IE, Isenberg DA. An update on autoantibodies in the idiopathic inflammatory myopathies. Nat Rev Rheumatol Jan. 2025;21(1):46\u201362. https:\/\/doi.org\/10.1038\/s41584-024-01188-4.","journal-title":"Nat Rev Rheumatol Jan"},{"issue":"7","key":"1219_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11926-021-01017-7","volume":"1","author":"A Uruha","year":"2021","unstructured":"Uruha A, Goebel HH, Stenzel W. Updates on the Immunopathology in Idiopathic Inflammatory Myopathies. Curr Rheumatol Rep Jul. 2021;1(7):56. https:\/\/doi.org\/10.1007\/s11926-021-01017-7.","journal-title":"Curr Rheumatol Rep Jul"},{"issue":"5","key":"1219_CR10","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/mus.28050","volume":"69","author":"YC Chang","year":"2024","unstructured":"Chang YC, Yang L, Budhram A. Positive predictive value of myositis antibody line blot testing in patients with suspected idiopathic inflammatory myopathy. Muscle Nerve May. 2024;69(5):626\u201330. https:\/\/doi.org\/10.1002\/mus.28050.","journal-title":"Muscle Nerve May"},{"issue":"2","key":"1219_CR11","doi-asserted-by":"publisher","first-page":"212","DOI":"10.55563\/clinexprheumatol\/3cuc1s","volume":"38","author":"Y Piette","year":"2020","unstructured":"Piette Y, De Sloovere M, Vandendriessche S, et al. Pitfalls in the detection of myositis specific antibodies by lineblot in clinically suspected idiopathic inflammatory myopathy. Clin Exp Rheumatol Mar-Apr. 2020;38(2):212\u20139. https:\/\/doi.org\/10.55563\/clinexprheumatol\/3cuc1s.","journal-title":"Clin Exp Rheumatol Mar-Apr"},{"issue":"9","key":"1219_CR12","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1093\/rheumatology\/keae167","volume":"63","author":"A Loganathan","year":"2024","unstructured":"Loganathan A, Gupta L, Rudge A, et al. Assessing the sensitivity and specificity of myositis-specific and associated autoantibodies: a sub-study from the MyoCite cohort. Rheumatology (Oxford). 2024;63(9):2363\u201371. . https:\/\/doi.org\/10.1093\/rheumatology\/keae167","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"1219_CR13","doi-asserted-by":"publisher","first-page":"102993","DOI":"10.1016\/j.autrev.2021.102993","volume":"21","author":"G Merlonghi","year":"2022","unstructured":"Merlonghi G, Antonini G, Garibaldi M. Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge. Autoimmun Rev Feb. 2022;21(2):102993. https:\/\/doi.org\/10.1016\/j.autrev.2021.102993.","journal-title":"Autoimmun Rev Feb"},{"issue":"1","key":"1219_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40478-022-01320-z","volume":"8","author":"N Becker","year":"2022","unstructured":"Becker N, Moore SA, Jones KA. The inflammatory pathology of dysferlinopathy is distinct from calpainopathy, Becker muscular dystrophy, and inflammatory myopathies. Acta Neuropathol Commun Feb. 2022;8(1):17. https:\/\/doi.org\/10.1186\/s40478-022-01320-z.","journal-title":"Acta Neuropathol Commun Feb"},{"issue":"9","key":"1219_CR15","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1093\/rheumatology\/kead052","volume":"62","author":"JC Milisenda","year":"2023","unstructured":"Milisenda JC, Pinal-Fernandez I, Lloyd TE, et al. The pattern of MHC class I expression in muscle biopsies from patients with myositis and other neuromuscular disorders. Rheumatology (Oxford). 2023;62(9):3156\u201360. . https:\/\/doi.org\/10.1093\/rheumatology\/kead052","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"1219_CR16","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.nmd.2014.06.436","volume":"24","author":"PM Rodriguez Cruz","year":"2014","unstructured":"Rodriguez Cruz PM, Luo YB, Miller J, Junckerstorff RC, Mastaglia FL, Fabian V. An analysis of the sensitivity and specificity of MHC-I and MHC-II immunohistochemical staining in muscle biopsies for the diagnosis of inflammatory myopathies. Neuromuscul Disord Dec. 2014;24(12):1025\u201335. https:\/\/doi.org\/10.1016\/j.nmd.2014.06.436.","journal-title":"Neuromuscul Disord Dec"},{"issue":"4","key":"1219_CR17","doi-asserted-by":"publisher","first-page":"427","DOI":"10.4103\/injr.injr_250_20","volume":"16","author":"S Ganguly","year":"2021","unstructured":"Ganguly S, Chatterjee R, Zanwar A, Gupta L. Myositis Mimics. Indian J Rheumatol. 2021;16(4):427\u201336.","journal-title":"Indian J Rheumatol"},{"issue":"2","key":"1219_CR18","doi-asserted-by":"publisher","first-page":"301","DOI":"10.55563\/clinexprheumatol\/dkmz6o","volume":"41","author":"S Barsotti","year":"2023","unstructured":"Barsotti S, Aringhieri G, Mugellini B, et al. The role of magnetic resonance imaging in the diagnostic work-out of myopathies: differential diagnosis between inflammatory myopathies and muscular dystrophies. Clin Exp Rheumatol Mar. 2023;41(2):301\u20138. https:\/\/doi.org\/10.55563\/clinexprheumatol\/dkmz6o.","journal-title":"Clin Exp Rheumatol Mar"},{"issue":"4","key":"1219_CR19","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/mus.23370","volume":"46","author":"AF Costa","year":"2012","unstructured":"Costa AF, Di Primio GA, Schweitzer ME. Magnetic resonance imaging of muscle disease: a pattern-based approach. Muscle Nerve Oct. 2012;46(4):465\u201381. https:\/\/doi.org\/10.1002\/mus.23370.","journal-title":"Muscle Nerve Oct"},{"issue":"1020","key":"1219_CR20","doi-asserted-by":"publisher","first-page":"e1298","DOI":"10.1259\/bjr\/14063641","volume":"85","author":"DJ Theodorou","year":"2012","unstructured":"Theodorou DJ, Theodorou SJ, Kakitsubata Y. Skeletal muscle disease: patterns of MRI appearances. Br J Radiol Dec. 2012;85(1020):e1298\u2013308. https:\/\/doi.org\/10.1259\/bjr\/14063641.","journal-title":"Br J Radiol Dec"},{"key":"1219_CR21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1148\/radiographics.20.suppl_1.g00oc18s295","volume":"20","author":"DA May","year":"2000","unstructured":"May DA, Disler DG, Jones EA, Balkissoon AA, Manaster BJ. Abnormal signal intensity in skeletal muscle at MR imaging: patterns, pearls, and pitfalls. Radiographics Oct. 2000;20:295\u2013315. https:\/\/doi.org\/10.1148\/radiographics.20.suppl_1.g00oc18s295. Spec No:S.","journal-title":"Radiographics Oct"},{"issue":"2","key":"1219_CR22","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1016\/S2665-9913(23)00322-3","volume":"6","author":"CM Connolly","year":"2024","unstructured":"Connolly CM, Gupta L, Fujimoto M, Machado PM, Paik JJ. Idiopathic inflammatory myopathies: current insights and future frontiers. Lancet Rheumatol Feb. 2024;6(2):e115\u201327. https:\/\/doi.org\/10.1016\/S2665-9913(23)00322-3.","journal-title":"Lancet Rheumatol Feb"},{"issue":"5","key":"1219_CR23","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41584-019-0186-x","volume":"15","author":"SA Greenberg","year":"2019","unstructured":"Greenberg SA. Inclusion body myositis: clinical features and pathogenesis. Nat Rev Rheumatol May. 2019;15(5):257\u201372. https:\/\/doi.org\/10.1038\/s41584-019-0186-x.","journal-title":"Nat Rev Rheumatol May"},{"issue":"7","key":"1219_CR24","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"13","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med Feb. 1975;13(7):344\u20137. https:\/\/doi.org\/10.1056\/NEJM197502132920706.","journal-title":"N Engl J Med Feb"},{"issue":"4","key":"1219_CR25","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3899\/jrheum.160871","volume":"44","author":"SL Tansley","year":"2017","unstructured":"Tansley SL, Betteridge ZE, Simou S, et al. Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients. J Rheumatol Apr. 2017;44(4):488\u201392. https:\/\/doi.org\/10.3899\/jrheum.160871.","journal-title":"J Rheumatol Apr"},{"issue":"4","key":"1219_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11926-018-0732-6","volume":"26","author":"I Pinal-Fernandez","year":"2018","unstructured":"Pinal-Fernandez I, Casal-Dominguez M, Mammen AL. Immune-Mediated Necrotizing Myopathy. Curr Rheumatol Rep Mar. 2018;26(4):21. https:\/\/doi.org\/10.1007\/s11926-018-0732-6.","journal-title":"Curr Rheumatol Rep Mar"},{"issue":"5","key":"1219_CR27","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1212\/cont.0000000000001615","volume":"31","author":"T Liewluck","year":"2025","unstructured":"Liewluck T. Oct. Limb-girdle muscular dystrophies. Continuum (Minneap Minn). 2025;31(5):1344\u201371. https:\/\/doi.org\/10.1212\/cont.0000000000001615","journal-title":"Continuum (Minneap Minn)"},{"issue":"6","key":"1219_CR28","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1002\/mus.27435","volume":"64","author":"S Nicolau","year":"2021","unstructured":"Nicolau S, Milone M, Tracy JA, Mills JR, Triplett JD, Liewluck T. Immune-mediated necrotizing myopathy: Unusual presentations of a treatable disease. Muscle Nerve Dec. 2021;64(6):734\u20139. https:\/\/doi.org\/10.1002\/mus.27435.","journal-title":"Muscle Nerve Dec"},{"issue":"1","key":"1219_CR29","doi-asserted-by":"publisher","first-page":"e523","DOI":"10.1212\/NXI.0000000000000523","volume":"6","author":"P Mohassel","year":"2019","unstructured":"Mohassel P, Landon-Cardinal O, Foley AR, et al. Anti-HMGCR myopathy may resemble limb-girdle muscular dystrophy. Neurol Neuroimmunol Neuroinflamm Jan. 2019;6(1):e523. https:\/\/doi.org\/10.1212\/NXI.0000000000000523.","journal-title":"Neurol Neuroimmunol Neuroinflamm Jan"},{"issue":"1","key":"1219_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/s0025-7125(16)31243-3","volume":"68","author":"RG Haller","year":"1984","unstructured":"Haller RG, Knochel JP. Skeletal muscle disease in alcoholism. Med Clin North Am Jan. 1984;68(1):91\u2013103. https:\/\/doi.org\/10.1016\/s0025-7125(16)31243-3.","journal-title":"Med Clin North Am Jan"},{"issue":"11","key":"1219_CR31","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1056\/NEJM198809153191103","volume":"15","author":"D Roth","year":"1988","unstructured":"Roth D, Alarcon FJ, Fernandez JA, Preston RA, Bourgoignie JJ. Acute rhabdomyolysis associated with cocaine intoxication. N Engl J Med Sep. 1988;15(11):673\u20137. https:\/\/doi.org\/10.1056\/NEJM198809153191103.","journal-title":"N Engl J Med Sep"},{"issue":"9","key":"1219_CR32","doi-asserted-by":"publisher","first-page":"e15337","DOI":"10.1111\/1756-185X.15337","volume":"27","author":"M Shah","year":"2024","unstructured":"Shah M, Shrestha K, Tseng CW, Goyal A, Liewluck T, Gupta L. Statin-associated muscle symptoms: A comprehensive exploration of epidemiology, pathophysiology, diagnosis, and clinical management strategies. Int J Rheum Dis Sep. 2024;27(9):e15337. https:\/\/doi.org\/10.1111\/1756-185X.15337.","journal-title":"Int J Rheum Dis Sep"},{"issue":"3","key":"1219_CR33","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1128\/CMR.00001-08","volume":"21","author":"NF Crum-Cianflone","year":"2008","unstructured":"Crum-Cianflone NF. Bacterial, fungal, parasitic, and viral myositis. Clin Microbiol Rev Jul. 2008;21(3):473\u201394. https:\/\/doi.org\/10.1128\/CMR.00001-08.","journal-title":"Clin Microbiol Rev Jul"},{"issue":"5","key":"1219_CR34","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1212\/cont.0000000000001620","volume":"31","author":"H Kushlaf","year":"2025","unstructured":"Kushlaf H. Muscle channelopathies and rhabdomyolysis. Continuum (Minneap Minn). 2025;31(5):1409\u201336. https:\/\/doi.org\/10.1212\/cont.0000000000001620","journal-title":"Continuum (Minneap Minn)"},{"key":"1219_CR35","doi-asserted-by":"publisher","unstructured":"Kruijt N, Laforet P, Vissing J et al. 276th ENMC International Workshop: recommendations on optimal diagnostic pathway and management strategy for patients with acute rhabdomyolysis worldwide. 15th-17th March 2024, Hoofddorp, The Netherlands. Neuromuscul Disord. 2025;50:105344. https:\/\/doi.org\/10.1016\/j.nmd.2025.105344","DOI":"10.1016\/j.nmd.2025.105344"},{"key":"1219_CR36","doi-asserted-by":"publisher","first-page":"123599","DOI":"10.1016\/j.jns.2025.123599","volume":"15","author":"FJS Jones","year":"2025","unstructured":"Jones FJS, Mirman I, Milone M, Liewluck T. Exposure to sertraline and ranolazine is common among adult patients with genetically uncharacterized lipid storage myopathy. J Neurol Sci Aug. 2025;15:475:123599. https:\/\/doi.org\/10.1016\/j.jns.2025.123599.","journal-title":"J Neurol Sci Aug"},{"key":"1219_CR37","doi-asserted-by":"publisher","first-page":"616075","DOI":"10.3389\/fneur.2020.616075","volume":"11","author":"E Naddaf","year":"2020","unstructured":"Naddaf E, Paul P, AbouEzzeddine OF. Chloroquine and Hydroxychloroquine Myopathy: Clinical Spectrum and Treatment Outcomes. Front Neurol. 2020;11:616075. https:\/\/doi.org\/10.3389\/fneur.2020.616075.","journal-title":"Front Neurol"},{"issue":"6","key":"1219_CR38","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1212\/CON.0000000000000806","volume":"25","author":"CT Doughty","year":"2019","unstructured":"Doughty CT, Amato AA. Toxic myopathies. Continuum (Minneap Minn). 2019;25(6):1712\u201331. . https:\/\/doi.org\/10.1212\/CON.0000000000000806","journal-title":"Continuum (Minneap Minn)"},{"issue":"6","key":"1219_CR39","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.nmd.2021.03.004","volume":"31","author":"P Paul","year":"2021","unstructured":"Paul P, Vazquez Do Campo R, Liewluck T, Naddaf E. Ranolazine-induced lipid storage myopathy presenting with respiratory failure and head drop. Neuromuscul Disord Jun. 2021;31(6):546\u201350. https:\/\/doi.org\/10.1016\/j.nmd.2021.03.004.","journal-title":"Neuromuscul Disord Jun"},{"issue":"2 Pt 1","key":"1219_CR40","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/0091-6749(85)90708-0","volume":"76","author":"SL Bowyer","year":"1985","unstructured":"Bowyer SL, LaMothe MP, Hollister JR. Steroid myopathy: incidence and detection in a population with asthma. J Allergy Clin Immunol Aug. 1985;76(2 Pt 1):234\u201342. https:\/\/doi.org\/10.1016\/0091-6749(85)90708-0.","journal-title":"J Allergy Clin Immunol Aug"},{"issue":"1","key":"1219_CR41","first-page":"62","volume":"9","author":"G Faludi","year":"1966","unstructured":"Faludi G, Gotlieb J, Meyers J. Factors influencing the development of steroid-induced myopathies. Ann N Y Acad Sci Sep. 1966;9(1):62\u201372.","journal-title":"Ann N Y Acad Sci Sep"},{"issue":"2","key":"1219_CR42","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1365-2265.1983.tb03198.x","volume":"18","author":"AA Khaleeli","year":"1983","unstructured":"Khaleeli AA, Edwards RH, Gohil K, et al. Corticosteroid myopathy: a clinical and pathological study. Clin Endocrinol (Oxf) Feb. 1983;18(2):155\u201366. https:\/\/doi.org\/10.1111\/j.1365-2265.1983.tb03198.x.","journal-title":"Clin Endocrinol (Oxf) Feb"},{"issue":"7","key":"1219_CR43","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1056\/NEJM198902163200701","volume":"16","author":"A Urbano-Marquez","year":"1989","unstructured":"Urbano-Marquez A, Estruch R, Navarro-Lopez F, Grau JM, Mont L, Rubin E. The effects of alcoholism on skeletal and cardiac muscle. N Engl J Med Feb. 1989;16(7):409\u201315. https:\/\/doi.org\/10.1056\/NEJM198902163200701.","journal-title":"N Engl J Med Feb"},{"issue":"3","key":"1219_CR44","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0022-510x(73)90185-8","volume":"20","author":"AJ Martinez","year":"1973","unstructured":"Martinez AJ, Hooshmand H, Faris AA. Acute alcoholic myopathy. Enzyme histochemistry and electron microscopic findings. J Neurol Sci Nov. 1973;20(3):245\u201352. https:\/\/doi.org\/10.1016\/0022-510x(73)90185-8.","journal-title":"J Neurol Sci Nov"},{"issue":"6","key":"1219_CR45","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/mus.20168","volume":"30","author":"A Urbano-Marquez","year":"2004","unstructured":"Urbano-Marquez A, Fernandez-Sola J. Effects of alcohol on skeletal and cardiac muscle. Muscle Nerve Dec. 2004;30(6):689\u2013707. https:\/\/doi.org\/10.1002\/mus.20168.","journal-title":"Muscle Nerve Dec"},{"issue":"5","key":"1219_CR46","first-page":"995","volume":"14","author":"GJ Carroll","year":"1987","unstructured":"Carroll GJ, Will RK, Peter JB, Garlepp MJ, Dawkins RL. Penicillamine induced polymyositis and dermatomyositis. J Rheumatol Oct. 1987;14(5):995\u20131001.","journal-title":"J Rheumatol Oct"},{"issue":"4","key":"1219_CR47","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/art.1780290416","volume":"29","author":"K Takahashi","year":"1986","unstructured":"Takahashi K, Ogita T, Okudaira H, Yoshinoya S, Yoshizawa H, Miyamoto T. D-penicillamine-induced polymyositis in patients with rheumatoid arthritis. Arthritis Rheum Apr. 1986;29(4):560\u20134. https:\/\/doi.org\/10.1002\/art.1780290416.","journal-title":"Arthritis Rheum Apr"},{"issue":"4","key":"1219_CR48","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/0002-9343(84)90371-1","volume":"77","author":"JT Halla","year":"1984","unstructured":"Halla JT, Fallahi S, Koopman WJ. Penicillamine-induced myositis. Observations and unique features in two patients and review of the literature. Am J Med. 1984;77(4):719\u201322. https:\/\/doi.org\/10.1016\/0002-9343(84)90371-1","journal-title":"Am J Med"},{"issue":"3","key":"1219_CR49","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/00131402-200403000-00002","volume":"5","author":"J Srinivasan","year":"2004","unstructured":"Srinivasan J, Wu CJ, Amato AA. Inflammatory myopathy associated with imatinib mesylate therapy. J Clin Neuromuscul Dis Mar. 2004;5(3):119\u201321. https:\/\/doi.org\/10.1097\/00131402-200403000-00002.","journal-title":"J Clin Neuromuscul Dis Mar"},{"issue":"12","key":"1219_CR50","doi-asserted-by":"publisher","first-page":"806","DOI":"10.2169\/internalmedicine.33.806","volume":"33","author":"M Matsuya","year":"1994","unstructured":"Matsuya M, Abe T, Tosaka M, et al. The first case of polymyositis associated with interferon therapy. Intern Med Dec. 1994;33(12):806\u20138. https:\/\/doi.org\/10.2169\/internalmedicine.33.806.","journal-title":"Intern Med Dec"},{"issue":"1\u20132","key":"1219_CR51","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s002960050103","volume":"19","author":"G Cirigliano","year":"1999","unstructured":"Cirigliano G, Della Rossa A, Tavoni A, Viacava P, Bombardieri S. Polymyositis occurring during alpha-interferon treatment for malignant melanoma: a case report and review of the literature. Rheumatol Int. 1999;19(1\u20132):65\u20137. https:\/\/doi.org\/10.1007\/s002960050103.","journal-title":"Rheumatol Int"},{"issue":"11","key":"1219_CR52","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1212\/wnl.54.11.2186","volume":"13","author":"GJ Hengstman","year":"2000","unstructured":"Hengstman GJ, Vogels OJ, ter Laak HJ, de Witte T, van Engelen BG. Myositis during long-term interferon-alpha treatment. Neurology Jun. 2000;13(11):2186. https:\/\/doi.org\/10.1212\/wnl.54.11.2186.","journal-title":"Neurology Jun"},{"key":"1219_CR53","doi-asserted-by":"publisher","first-page":"179180","DOI":"10.1155\/2014\/179180","volume":"2014","author":"AM Brunasso","year":"2014","unstructured":"Brunasso AM, Aberer W, Massone C. New onset of dermatomyositis\/polymyositis during anti-TNF-alpha therapies: a systematic literature review. ScientificWorldJournal. 2014;2014:179180. https:\/\/doi.org\/10.1155\/2014\/179180.","journal-title":"ScientificWorldJournal"},{"issue":"6","key":"1219_CR54","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.rbre.2016.05.003","volume":"57","author":"O Zengin","year":"2017","unstructured":"Zengin O, Onder ME, Alkan S, et al. Three cases of anti-TNF induced myositis and literature review. Rev Bras Reumatol Engl Ed Nov-Dec. 2017;57(6):590\u20135. https:\/\/doi.org\/10.1016\/j.rbre.2016.05.003.","journal-title":"Rev Bras Reumatol Engl Ed Nov-Dec"},{"issue":"3","key":"1219_CR55","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/0002-9343(87)90444-x","volume":"82","author":"ML Estes","year":"1987","unstructured":"Estes ML, Ewing-Wilson D, Chou SM, et al. Chloroquine neuromyotoxicity. Clinical and pathologic perspective. Am J Med. 1987;82(3):447\u201355. https:\/\/doi.org\/10.1016\/0002-9343(87)90444-x","journal-title":"Am J Med"},{"issue":"5","key":"1219_CR56","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/s0002-8703(05)80264-9","volume":"119","author":"R Fernando Roth","year":"1990","unstructured":"Fernando Roth R, Itabashi H, Louie J, Anderson T, Narahara KA. Amiodarone toxicity: myopathy and neuropathy. Am Heart J May. 1990;119(5):1223\u20135. https:\/\/doi.org\/10.1016\/s0002-8703(05)80264-9.","journal-title":"Am Heart J May"},{"issue":"3","key":"1219_CR57","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/00131402-200203000-00001","volume":"3","author":"U Pulipaka","year":"2002","unstructured":"Pulipaka U, Lacomis D, Omalu B. Amiodarone-induced neuromyopathy: three cases and a review of the literature. J Clin Neuromuscul Dis Mar. 2002;3(3):97\u2013105. https:\/\/doi.org\/10.1097\/00131402-200203000-00001.","journal-title":"J Clin Neuromuscul Dis Mar"},{"issue":"25","key":"1219_CR58","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1056\/NEJM198706183162502","volume":"18","author":"RW Kuncl","year":"1987","unstructured":"Kuncl RW, Duncan G, Watson D, Alderson K, Rogawski MA, Peper M. Colchicine myopathy and neuropathy. N Engl J Med Jun. 1987;18(25):1562\u20138. https:\/\/doi.org\/10.1056\/NEJM198706183162502.","journal-title":"N Engl J Med Jun"},{"key":"1219_CR59","doi-asserted-by":"crossref","unstructured":"Rutkove SB, De Girolami U, Preston DC, et al. Myotonia in colchicine myoneuropathy. Muscle Nerve Jul. 1996;19(7):870\u20135. https:\/\/doi.org\/10.1002\/(SICI)1097-4598(199607)19:7<870::AID-MUS9>3.0.CO;2-6.","DOI":"10.1002\/(SICI)1097-4598(199607)19:7<870::AID-MUS9>3.0.CO;2-6"},{"issue":"2","key":"1219_CR60","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0022-510x(70)90013-4","volume":"10","author":"WG Bradley","year":"1970","unstructured":"Bradley WG, Lassman LP, Pearce GW, Walton JN. The neuromyopathy of vincristine in man. Clinical, electrophysiological and pathological studies. J Neurol Sci Feb. 1970;10(2):107\u201331. https:\/\/doi.org\/10.1016\/0022-510x(70)90013-4.","journal-title":"J Neurol Sci Feb"},{"issue":"16","key":"1219_CR61","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1056\/NEJM199004193221602","volume":"19","author":"MC Dalakas","year":"1990","unstructured":"Dalakas MC, Illa I, Pezeshkpour GH, Laukaitis JP, Cohen B, Griffin JL. Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med Apr. 1990;19(16):1098\u2013105. https:\/\/doi.org\/10.1056\/NEJM199004193221602.","journal-title":"N Engl J Med Apr"},{"issue":"11","key":"1219_CR62","doi-asserted-by":"publisher","first-page":"e210031","DOI":"10.1212\/WNL.0000000000210031","volume":"10","author":"G Beecher","year":"2024","unstructured":"Beecher G, Pinal-Fernandez I, Mammen AL, Liewluck T. Immune Checkpoint Inhibitor Myopathy: The Double-Edged Sword of Cancer Immunotherapy. Neurology Dec. 2024;10(11):e210031. https:\/\/doi.org\/10.1212\/WNL.0000000000210031.","journal-title":"Neurology Dec"},{"key":"1219_CR63","doi-asserted-by":"publisher","unstructured":"Katzberg HD, Kassardjian CD. Toxic and endocrine myopathies. Continuum (Minneap Minn). 2016;22(6, Muscle and Neuromuscular Junction Disorders):1815\u20131828. https:\/\/doi.org\/10.1212\/CON.0000000000000407","DOI":"10.1212\/CON.0000000000000407"},{"issue":"1","key":"1219_CR64","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/s0733-8619(05)70186-9","volume":"18","author":"HA Horak","year":"2000","unstructured":"Horak HA, Pourmand R. Feb. Endocrine myopathies. Neurol Clin. 2000;18(1):203\u2009\u2013\u200913. https:\/\/doi.org\/10.1016\/s0733-8619(05)70186-9","journal-title":"Neurol Clin"},{"issue":"4","key":"1219_CR65","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s11154-016-9357-0","volume":"17","author":"A Sindoni","year":"2016","unstructured":"Sindoni A, Rodolico C, Pappalardo MA, Portaro S, Benvenga S. Hypothyroid myopathy: A peculiar clinical presentation of thyroid failure. Review of the literature. Rev Endocr Metab Disord Dec. 2016;17(4):499\u2013519. https:\/\/doi.org\/10.1007\/s11154-016-9357-0.","journal-title":"Rev Endocr Metab Disord Dec"},{"key":"1219_CR66","unstructured":"Fariduddin MM, Haq N, Bansal N. Hypothyroid Myopathy. StatPearls. 2025."},{"issue":"2","key":"1219_CR67","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1046\/j.1365-2265.1999.00790.x","volume":"51","author":"F Monzani","year":"1999","unstructured":"Monzani F, Caraccio N, Del Guerra P, Casolaro A, Ferrannini E. Neuromuscular symptoms and dysfunction in subclinical hypothyroid patients: beneficial effect of L-T4 replacement therapy. Clin Endocrinol (Oxf) Aug. 1999;51(2):237\u201342. https:\/\/doi.org\/10.1046\/j.1365-2265.1999.00790.x.","journal-title":"Clin Endocrinol (Oxf) Aug"},{"issue":"2","key":"1219_CR68","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1089\/thy.1991.1.137","volume":"1","author":"BR Olson","year":"1991","unstructured":"Olson BR, Klein I, Benner R, Burdett R, Trzepacz P, Levey GS. Hyperthyroid myopathy and the response to treatment. Thyroid. 1991;1(2):137\u201341. https:\/\/doi.org\/10.1089\/thy.1991.1.137.","journal-title":"Thyroid"},{"issue":"8","key":"1219_CR69","first-page":"315","volume":"75","author":"M Salih","year":"2017","unstructured":"Salih M, van Kinschot CMJ, Peeters RP, et al. Thyrotoxic periodic paralysis: an unusual presentation of hyperthyroidism. Neth J Med Oct. 2017;75(8):315\u201320.","journal-title":"Neth J Med Oct"},{"issue":"4","key":"1219_CR70","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1136\/jnnp.21.4.270","volume":"21","author":"R Hed","year":"1958","unstructured":"Hed R, Kirstein L, Lundmark C. Thyrotoxic myopathy. J Neurol Neurosurg Psychiatry Nov. 1958;21(4):270\u20138. https:\/\/doi.org\/10.1136\/jnnp.21.4.270.","journal-title":"J Neurol Neurosurg Psychiatry Nov"},{"issue":"6","key":"1219_CR71","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1136\/jnnp.50.6.817","volume":"50","author":"H Yamaguchi","year":"1987","unstructured":"Yamaguchi H, Okamoto K, Shooji M, Morimatsu M, Hirai S. Muscle histology of hypocalcaemic myopathy in hypoparathyroidism. J Neurol Neurosurg Psychiatry Jun. 1987;50(6):817\u20138. https:\/\/doi.org\/10.1136\/jnnp.50.6.817.","journal-title":"J Neurol Neurosurg Psychiatry Jun"},{"issue":"6","key":"1219_CR72","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/s0002-9343(70)80004-3","volume":"48","author":"EJ Cholod","year":"1970","unstructured":"Cholod EJ, Haust MD, Hudson AJ, Lewis FN. Myopathy in primary familial hyperparathyroidism. Clinical and morphologic studies. Am J Med. Jun 1970;48(6):700\u20137. https:\/\/doi.org\/10.1016\/s0002-9343(70)80004-3","journal-title":"Am J Med"},{"key":"1219_CR73","doi-asserted-by":"publisher","first-page":"764346","DOI":"10.3389\/fmed.2021.764346","volume":"8","author":"C Romagnoli","year":"2021","unstructured":"Romagnoli C, Brandi ML. Muscle Physiopathology in Parathyroid Hormone Disorders. Front Med (Lausanne). 2021;8:764346. https:\/\/doi.org\/10.3389\/fmed.2021.764346.","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"1219_CR74","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/j.biocel.2013.05.036","volume":"45","author":"O Schakman","year":"2013","unstructured":"Schakman O, Kalista S, Barbe C, Loumaye A, Thissen JP. Glucocorticoid-induced skeletal muscle atrophy. Int J Biochem Cell Biol Oct. 2013;45(10):2163\u201372. https:\/\/doi.org\/10.1016\/j.biocel.2013.05.036.","journal-title":"Int J Biochem Cell Biol Oct"},{"issue":"3","key":"1219_CR75","doi-asserted-by":"publisher","first-page":"130","DOI":"10.36185\/2532-1900-017","volume":"39","author":"C Rodolico","year":"2020","unstructured":"Rodolico C, Bonanno C, Pugliese A, Nicocia G, Benvenga S, Toscano A. Endocrine myopathies: clinical and histopathological features of the major forms. Acta Myol Sep. 2020;39(3):130\u20135. https:\/\/doi.org\/10.36185\/2532-1900-017.","journal-title":"Acta Myol Sep"},{"issue":"6","key":"1219_CR76","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.3892\/etm.2016.3864","volume":"12","author":"C Wu","year":"2016","unstructured":"Wu C, Xin J, Xin M, et al. Hypokalemic myopathy in primary aldosteronism: A case report. Exp Ther Med Dec. 2016;12(6):4064\u20136. https:\/\/doi.org\/10.3892\/etm.2016.3864.","journal-title":"Exp Ther Med Dec"},{"issue":"5","key":"1219_CR77","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1212\/cont.0000000000001617","volume":"31","author":"MK Salajegheh","year":"2025","unstructured":"Salajegheh MK, Amato AA. Idiopathic inflammatory myopathies. Continuum (Minneap Minn). 2025;31(5):1385\u2013408. . https:\/\/doi.org\/10.1212\/cont.0000000000001617","journal-title":"Continuum (Minneap Minn)"},{"issue":"21","key":"1219_CR78","doi-asserted-by":"publisher","first-page":"e2653","DOI":"10.1212\/WNL.0000000000012004","volume":"25","author":"S Shelly","year":"2021","unstructured":"Shelly S, Mielke MM, Mandrekar J, et al. Epidemiology and Natural History of Inclusion Body Myositis: A 40-Year Population-Based Study. Neurology May. 2021;25(21):e2653\u201361. https:\/\/doi.org\/10.1212\/WNL.0000000000012004.","journal-title":"Neurology May"},{"issue":"2","key":"1219_CR79","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1001\/jama.2010.1977","volume":"12","author":"LG Rider","year":"2011","unstructured":"Rider LG, Miller FW. Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies. JAMA Jan. 2011;12(2):183\u201390. https:\/\/doi.org\/10.1001\/jama.2010.1977.","journal-title":"JAMA Jan"},{"issue":"5","key":"1219_CR80","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.mayocp.2016.12.025","volume":"92","author":"M Milone","year":"2017","unstructured":"Milone M. Diagnosis and Management of Immune-Mediated Myopathies. Mayo Clin Proc. 2017;92(5):826\u201337. https:\/\/doi.org\/10.1016\/j.mayocp.2016.12.025","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"1219_CR81","doi-asserted-by":"publisher","first-page":"101503","DOI":"10.1016\/j.berh.2020.101503","volume":"34","author":"JL Marco","year":"2020","unstructured":"Marco JL, Collins BF. Clinical manifestations and treatment of antisynthetase syndrome. Best Pract Res Clin Rheumatol Aug. 2020;34(4):101503. https:\/\/doi.org\/10.1016\/j.berh.2020.101503.","journal-title":"Best Pract Res Clin Rheumatol Aug"},{"issue":"2","key":"1219_CR82","doi-asserted-by":"publisher","first-page":"fcaa181","DOI":"10.1093\/braincomms\/fcaa181","volume":"2","author":"S Shelly","year":"2020","unstructured":"Shelly S, Triplett JD, Pinto MV, et al. Immune checkpoint inhibitor-associated myopathy: a clinicoseropathologically distinct myopathy. Brain Commun. 2020;2(2):fcaa181. https:\/\/doi.org\/10.1093\/braincomms\/fcaa181.","journal-title":"Brain Commun"},{"issue":"5","key":"1219_CR83","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1097\/00005792-200109000-00006","volume":"80","author":"KJ Felice","year":"2001","unstructured":"Felice KJ, North WA. Inclusion body myositis in Connecticut: observations in 35 patients during an 8-year period. Medicine (Baltimore) Sep. 2001;80(5):320\u20137. https:\/\/doi.org\/10.1097\/00005792-200109000-00006.","journal-title":"Medicine (Baltimore) Sep"},{"issue":"9","key":"1219_CR84","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1136\/jnnp.2007.138891","volume":"79","author":"M Needham","year":"2008","unstructured":"Needham M, James I, Corbett A, et al. Sporadic inclusion body myositis: phenotypic variability and influence of HLA-DR3 in a cohort of 57 Australian cases. J Neurol Neurosurg Psychiatry Sep. 2008;79(9):1056\u201360. https:\/\/doi.org\/10.1136\/jnnp.2007.138891.","journal-title":"J Neurol Neurosurg Psychiatry Sep"},{"key":"1219_CR85","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jocn.2019.04.002","volume":"65","author":"M Liu","year":"2019","unstructured":"Liu M, Hou Y, Dai T, et al. The clinical and histopathological features of idiopathic inflammatory myopathies with asymmetric muscle involvement. J Clin Neurosci Jul. 2019;65:46\u201353. https:\/\/doi.org\/10.1016\/j.jocn.2019.04.002.","journal-title":"J Clin Neurosci Jul"},{"issue":"2","key":"1219_CR86","doi-asserted-by":"publisher","first-page":"445","DOI":"10.55563\/clinexprheumatol\/fhrx3q","volume":"42","author":"B Roy","year":"2024","unstructured":"Roy B, Dimachkie MM, Naddaf E. Phenotypic spectrum of inclusion body myositis. Clin Exp Rheumatol Feb. 2024;42(2):445\u201353. https:\/\/doi.org\/10.55563\/clinexprheumatol\/fhrx3q.","journal-title":"Clin Exp Rheumatol Feb"},{"issue":"6","key":"1219_CR87","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1212\/CON.0000000000000801","volume":"25","author":"KR Wagner","year":"2019","unstructured":"Wagner KR. Facioscapulohumeral muscular dystrophies. Continuum (Minneap Minn). 2019;25(6):1662\u201381. https:\/\/doi.org\/10.1212\/CON.0000000000000801","journal-title":"Continuum (Minneap Minn)"},{"key":"1219_CR88","doi-asserted-by":"publisher","unstructured":"Soontrapa P, Liewluck T. Anoctamin 5 (ANO5) muscle disorders: A narrative review. Genes (Basel) 2022;27(10). https:\/\/doi.org\/10.3390\/genes13101736","DOI":"10.3390\/genes13101736"},{"issue":"4","key":"1219_CR89","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.nmd.2018.02.002","volume":"28","author":"KJ Felice","year":"2018","unstructured":"Felice KJ, Whitaker CH, Wu Q. Whole exome sequencing discloses a pathogenic MTM1 gene mutation and ends the diagnostic odyssey in an older woman with a progressive and seemingly sporadic myopathy: Case report and literature review of MTM1 manifesting female carriers. Neuromuscul Disord Apr. 2018;28(4):339\u201345. https:\/\/doi.org\/10.1016\/j.nmd.2018.02.002.","journal-title":"Neuromuscul Disord Apr"},{"issue":"3","key":"1219_CR90","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s00415-025-12987-4","volume":"4","author":"P Riguzzi","year":"2025","unstructured":"Riguzzi P, Sabbatini D, Fusto A, et al. Deep characterization of females with heterozygous Duchenne muscular dystrophy mutations. J Neurol Mar. 2025;4(3):244. https:\/\/doi.org\/10.1007\/s00415-025-12987-4.","journal-title":"J Neurol Mar"},{"issue":"4","key":"1219_CR91","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/mus.26914","volume":"62","author":"S Nicolau","year":"2020","unstructured":"Nicolau S, Liewluck T, Milone M. Myopathies with finger flexor weakness: Not only inclusion-body myositis. Muscle Nerve Oct. 2020;62(4):445\u201354. https:\/\/doi.org\/10.1002\/mus.26914.","journal-title":"Muscle Nerve Oct"},{"issue":"6","key":"1219_CR92","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/mus.27716","volume":"66","author":"M Alamr","year":"2022","unstructured":"Alamr M, Pinto MV, Naddaf E. Atypical presentations of inclusion body myositis: Clinical characteristics and long-term outcomes. Muscle Nerve Dec. 2022;66(6):686\u201393. https:\/\/doi.org\/10.1002\/mus.27716.","journal-title":"Muscle Nerve Dec"},{"issue":"3","key":"1219_CR93","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/mus.26332","volume":"59","author":"M Milone","year":"2019","unstructured":"Milone M, Liewluck T. The unfolding spectrum of inherited distal myopathies. Muscle Nerve Mar. 2019;59(3):283\u201394. https:\/\/doi.org\/10.1002\/mus.26332.","journal-title":"Muscle Nerve Mar"},{"issue":"3","key":"1219_CR94","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/mus.26996","volume":"62","author":"JD Triplett","year":"2020","unstructured":"Triplett JD, Pinto MV, Hosfield EA, Milone M, Liewluck T. Myopathies featuring early or prominent dysphagia. Muscle Nerve Sep. 2020;62(3):344\u201350. https:\/\/doi.org\/10.1002\/mus.26996.","journal-title":"Muscle Nerve Sep"},{"issue":"9","key":"1219_CR95","doi-asserted-by":"publisher","first-page":"e14572","DOI":"10.1111\/nmo.14572","volume":"35","author":"I Cheng","year":"2023","unstructured":"Cheng I, Wong CS. A systematic review and meta-analysis on the prevalence and clinical characteristics of dysphagia in patients with dermatomyositis. Neurogastroenterol Motil Sep. 2023;35(9):e14572. https:\/\/doi.org\/10.1111\/nmo.14572.","journal-title":"Neurogastroenterol Motil Sep"},{"issue":"5","key":"1219_CR96","doi-asserted-by":"publisher","first-page":"e0154746","DOI":"10.1371\/journal.pone.0154746","volume":"11","author":"N Mugii","year":"2016","unstructured":"Mugii N, Hasegawa M, Matsushita T, et al. Oropharyngeal Dysphagia in Dermatomyositis: Associations with Clinical and Laboratory Features Including Autoantibodies. PLoS ONE. 2016;11(5):e0154746. https:\/\/doi.org\/10.1371\/journal.pone.0154746.","journal-title":"PLoS ONE"},{"issue":"4","key":"1219_CR97","doi-asserted-by":"publisher","first-page":"441","DOI":"10.4065\/82.4.441","volume":"82","author":"TH Oh","year":"2007","unstructured":"Oh TH, Brumfield KA, Hoskin TL, Stolp KA, Murray JA, Bassford JR. Dysphagia in inflammatory myopathy: clinical characteristics, treatment strategies, and outcome in 62 patients. Mayo Clin Proc. 2007;82(4):441\u20137. . https:\/\/doi.org\/10.4065\/82.4.441","journal-title":"Mayo Clin Proc"},{"key":"1219_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nmd.2024.06.005","volume":"42","author":"B Putko","year":"2024","unstructured":"Putko B, Pestronk A, Van Stavern GP, Phan CL, Beecher G, Liewluck T. Ophthalmoparesis as an unusual manifestation of anti-3\u2013hydroxy-3-methyl-glutaryl-coenzyme A reductase antibody-associated myopathies. Neuromuscul Disord Sep. 2024;42:1\u20134. https:\/\/doi.org\/10.1016\/j.nmd.2024.06.005.","journal-title":"Neuromuscul Disord Sep"},{"key":"1219_CR99","doi-asserted-by":"publisher","unstructured":"Okiyama N, Fujimoto M. Cutaneous manifestations of dermatomyositis characterized by myositis-specific autoantibodies. F1000Res. 2019;8. https:\/\/doi.org\/10.12688\/f1000research.20646.1","DOI":"10.12688\/f1000research.20646.1"},{"issue":"6","key":"1219_CR100","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1111\/bjd.17026","volume":"179","author":"S Inoue","year":"2018","unstructured":"Inoue S, Okiyama N, Shobo M, et al. Diffuse erythema with \u2018angel wings\u2019 sign in Japanese patients with anti-small ubiquitin-like modifier activating enzyme antibody-associated dermatomyositis. Br J Dermatol Dec. 2018;179(6):1414\u20135. https:\/\/doi.org\/10.1111\/bjd.17026.","journal-title":"Br J Dermatol Dec"},{"key":"1219_CR101","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2147\/ITT.S381472","volume":"13","author":"L Cassard","year":"2024","unstructured":"Cassard L, Seraly N, Riegert M, Patel A, Fernandez AP. Dermatomyositis: Practical Guidance and Unmet Needs. Immunotargets Ther. 2024;13:151\u201372. https:\/\/doi.org\/10.2147\/ITT.S381472.","journal-title":"Immunotargets Ther"},{"issue":"7","key":"1219_CR102","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1001\/jamaneurol.2020.0673","volume":"1","author":"M Inoue","year":"2020","unstructured":"Inoue M, Tanboon J, Hirakawa S, et al. Association of Dermatomyositis Sine Dermatitis With Anti-Nuclear Matrix Protein 2 Autoantibodies. JAMA Neurol Jul. 2020;1(7):872\u20137. https:\/\/doi.org\/10.1001\/jamaneurol.2020.0673.","journal-title":"JAMA Neurol Jul"},{"issue":"1","key":"1219_CR103","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.semarthrit.2020.09.020","volume":"51","author":"AH Opinc","year":"2021","unstructured":"Opinc AH, Makowska JS. Antisynthetase syndrome - much more than just a myopathy. Semin Arthritis Rheum Feb. 2021;51(1):72\u201383. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.09.020.","journal-title":"Semin Arthritis Rheum Feb"},{"issue":"7","key":"1219_CR104","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1007\/s10067-017-3598-5","volume":"36","author":"JT Cox","year":"2017","unstructured":"Cox JT, Gullotti DM, Mecoli CA, et al. Hiker\u2019s feet: a novel cutaneous finding in the inflammatory myopathies. Clin Rheumatol Jul. 2017;36(7):1683\u20136. https:\/\/doi.org\/10.1007\/s10067-017-3598-5.","journal-title":"Clin Rheumatol Jul"},{"issue":"7","key":"1219_CR105","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.autrev.2019.05.002","volume":"18","author":"JB Vulsteke","year":"2019","unstructured":"Vulsteke JB, Satoh M, Malyavantham K, Bossuyt X, De Langhe E, Mahler M. Anti-OJ autoantibodies: Rare or underdetected? Autoimmun Rev Jul. 2019;18(7):658\u201364. https:\/\/doi.org\/10.1016\/j.autrev.2019.05.002.","journal-title":"Autoimmun Rev Jul"},{"key":"1219_CR106","doi-asserted-by":"publisher","first-page":"102691","DOI":"10.1016\/j.jaut.2021.102691","volume":"123","author":"B Williams","year":"2021","unstructured":"Williams B, Horn MP, Banz Y, Feldmeyer L, Villiger PM. Cutaneous involvement in anti-HMGCR positive necrotizing myopathy. J Autoimmun Sep. 2021;123:102691. https:\/\/doi.org\/10.1016\/j.jaut.2021.102691.","journal-title":"J Autoimmun Sep"},{"issue":"2","key":"1219_CR107","doi-asserted-by":"publisher","first-page":"373","DOI":"10.55563\/clinexprheumatol\/brvl1v","volume":"40","author":"RW Hallowell","year":"2022","unstructured":"Hallowell RW, Paik JJ. Myositis-associated interstitial lung disease: a comprehensive approach to diagnosis and management. Clin Exp Rheumatol Feb. 2022;40(2):373\u201383. https:\/\/doi.org\/10.55563\/clinexprheumatol\/brvl1v.","journal-title":"Clin Exp Rheumatol Feb"},{"issue":"5","key":"1219_CR108","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/mus.25602","volume":"56","author":"E Naddaf","year":"2017","unstructured":"Naddaf E, Milone M. Hereditary myopathies with early respiratory insufficiency in adults. Muscle Nerve Nov. 2017;56(5):881\u20136. https:\/\/doi.org\/10.1002\/mus.25602.","journal-title":"Muscle Nerve Nov"},{"issue":"12","key":"1219_CR109","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11926-019-0878-x","volume":"7","author":"M Klein","year":"2019","unstructured":"Klein M, Mann H, Vencovsky J. Arthritis in Idiopathic Inflammatory Myopathies. Curr Rheumatol Rep Dec. 2019;7(12):70. https:\/\/doi.org\/10.1007\/s11926-019-0878-x.","journal-title":"Curr Rheumatol Rep Dec"},{"issue":"9","key":"1219_CR110","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S1474-4422(18)30254-0","volume":"17","author":"A Selva-O\u2019Callaghan","year":"2018","unstructured":"Selva-O\u2019Callaghan A, Pinal-Fernandez I, Trallero-Araguas E, Milisenda JC, Grau-Junyent JM, Mammen AL. Classification and management of adult inflammatory myopathies. Lancet Neurol Sep. 2018;17(9):816\u201328. https:\/\/doi.org\/10.1016\/S1474-4422(18)30254-0.","journal-title":"Lancet Neurol Sep"},{"issue":"2","key":"1219_CR111","doi-asserted-by":"publisher","first-page":"e16117","DOI":"10.1111\/ene.16117","volume":"31","author":"P Soontrapa","year":"2024","unstructured":"Soontrapa P, Shahar S, Eauchai L, Ernste FC, Liewluck T. Disease spectrum of myopathies with elevated aldolase and normal creatine kinase. Eur J Neurol Feb. 2024;31(2):e16117. https:\/\/doi.org\/10.1111\/ene.16117.","journal-title":"Eur J Neurol Feb"},{"key":"1219_CR112","doi-asserted-by":"publisher","unstructured":"Lilleker JB, Naddaf E, Saris CGJ et al. Apr. 272nd ENMC international workshop: 10 Years of progress - revision of the ENMC 2013 diagnostic criteria for inclusion body myositis and clinical trial readiness. 16\u201318 June 2023, Hoofddorp, The Netherlands. Neuromuscul Disord. 2024;37:36\u201351. https:\/\/doi.org\/10.1016\/j.nmd.2024.03.001","DOI":"10.1016\/j.nmd.2024.03.001"},{"issue":"11","key":"1219_CR113","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1136\/annrheumdis-2017-212701","volume":"77","author":"AN Malaviya","year":"2018","unstructured":"Malaviya AN. 2017 EULAR\/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: little emphasis on autoantibodies, why? Ann Rheum Dis Nov. 2018;77(11):e77. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212701.","journal-title":"Ann Rheum Dis Nov"},{"issue":"1","key":"1219_CR114","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13075-020-02210-2","volume":"15","author":"SL Tansley","year":"2020","unstructured":"Tansley SL, Snowball J, Pauling JD, et al. The promise, perceptions, and pitfalls of immunoassays for autoantibody testing in myositis. Arthritis Res Ther May. 2020;15(1):117. https:\/\/doi.org\/10.1186\/s13075-020-02210-2.","journal-title":"Arthritis Res Ther May"},{"issue":"4","key":"1219_CR115","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/mus.27157","volume":"63","author":"P Paul","year":"2021","unstructured":"Paul P, Liewluck T, Ernste FC, Mandrekar J, Milone M. Anti-cN1A antibodies do not correlate with specific clinical, electromyographic, or pathological findings in sporadic inclusion body myositis. Muscle Nerve Apr. 2021;63(4):490\u20136. https:\/\/doi.org\/10.1002\/mus.27157.","journal-title":"Muscle Nerve Apr"},{"issue":"19","key":"1219_CR116","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1212\/WNL.0000000000004610","volume":"7","author":"T Liewluck","year":"2017","unstructured":"Liewluck T. Anti-cytosolic 5\u2019-nucleotidase 1A (cN1A) autoantibodies in motor neuron diseases. Neurology Nov. 2017;7(19):2017\u20138. https:\/\/doi.org\/10.1212\/WNL.0000000000004610.","journal-title":"Neurology Nov"},{"issue":"4","key":"1219_CR117","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1136\/annrheumdis-2014-206691","volume":"75","author":"MK Herbert","year":"2016","unstructured":"Herbert MK, Stammen-Vogelzangs J, Verbeek MM, et al. Disease specificity of autoantibodies to cytosolic 5\u2019-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases. Ann Rheum Dis Apr. 2016;75(4):696\u2013701. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206691.","journal-title":"Ann Rheum Dis Apr"},{"key":"1219_CR118","doi-asserted-by":"publisher","first-page":"1146015","DOI":"10.3389\/fneur.2023.1146015","volume":"14","author":"AS Zubair","year":"2023","unstructured":"Zubair AS, Salam S, Dimachkie MM, Machado PM, Roy B. Imaging biomarkers in the idiopathic inflammatory myopathies. Front Neurol. 2023;14:1146015. https:\/\/doi.org\/10.3389\/fneur.2023.1146015.","journal-title":"Front Neurol"},{"issue":"2","key":"1219_CR119","doi-asserted-by":"publisher","first-page":"e2431359","DOI":"10.2214\/AJR.24.31359","volume":"223","author":"ED van Zandee","year":"2024","unstructured":"van Zandee ED, Yao L, Stevens KJ, Chung LS, Fiorentino DF, Boutin RD. Myositis and Its Mimics: Guideline Updates, MRI Characteristics, and New Horizons. AJR Am J Roentgenol Aug. 2024;223(2):e2431359. https:\/\/doi.org\/10.2214\/AJR.24.31359.","journal-title":"AJR Am J Roentgenol Aug"},{"issue":"6","key":"1219_CR120","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/BOR.0000000000000326","volume":"28","author":"N Pipitone","year":"2016","unstructured":"Pipitone N. Value of MRI in diagnostics and evaluation of myositis. Curr Opin Rheumatol Nov. 2016;28(6):625\u201330. https:\/\/doi.org\/10.1097\/BOR.0000000000000326.","journal-title":"Curr Opin Rheumatol Nov"},{"issue":"8","key":"1219_CR121","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/ard.46.8.569","volume":"46","author":"LD Kaufman","year":"1987","unstructured":"Kaufman LD, Gruber BL, Gerstman DP, Kaell AT. Preliminary observations on the role of magnetic resonance imaging for polymyositis and dermatomyositis. Ann Rheum Dis Aug. 1987;46(8):569\u201372. https:\/\/doi.org\/10.1136\/ard.46.8.569.","journal-title":"Ann Rheum Dis Aug"},{"issue":"1","key":"1219_CR122","doi-asserted-by":"publisher","first-page":"e000850","DOI":"10.1136\/rmdopen-2018-000850","volume":"5","author":"T Ukichi","year":"2019","unstructured":"Ukichi T, Yoshida K, Matsushima S, et al. MRI of skeletal muscles in patients with idiopathic inflammatory myopathies: characteristic findings and diagnostic performance in dermatomyositis. RMD Open. 2019;5(1):e000850. https:\/\/doi.org\/10.1136\/rmdopen-2018-000850.","journal-title":"RMD Open"},{"key":"1219_CR123","doi-asserted-by":"publisher","first-page":"109812","DOI":"10.1016\/j.ejrad.2021.109812","volume":"141","author":"S Spalkit","year":"2021","unstructured":"Spalkit S, Sinha A, Prakash M, Sandhu MS. Dermatomyositis: Patterns of MRI findings in muscles, fascia and skin of pelvis and thigh. Eur J Radiol Aug. 2021;141:109812. https:\/\/doi.org\/10.1016\/j.ejrad.2021.109812.","journal-title":"Eur J Radiol Aug"},{"issue":"2","key":"1219_CR124","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1007\/s00415-022-11447-7","volume":"270","author":"L Fionda","year":"2023","unstructured":"Fionda L, Lauletta A, Leonardi L, et al. Muscle MRI in immune-mediated necrotizing myopathy (IMNM): implications for clinical management and treatment strategies. J Neurol Feb. 2023;270(2):960\u201374. https:\/\/doi.org\/10.1007\/s00415-022-11447-7.","journal-title":"J Neurol Feb"},{"issue":"4","key":"1219_CR125","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1136\/annrheumdis-2016-210198","volume":"76","author":"I Pinal-Fernandez","year":"2017","unstructured":"Pinal-Fernandez I, Casal-Dominguez M, Carrino JA, et al. Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity. Ann Rheum Dis Apr. 2017;76(4):681\u20137. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210198.","journal-title":"Ann Rheum Dis Apr"},{"issue":"5","key":"1219_CR126","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/mus.26660","volume":"60","author":"JA Day","year":"2019","unstructured":"Day JA, Bajic N, Gentili S, Patel S, Limaye V. Radiographic patterns of muscle involvement in the idiopathic inflammatory myopathies. Muscle Nerve Nov. 2019;60(5):549\u201357. https:\/\/doi.org\/10.1002\/mus.26660.","journal-title":"Muscle Nerve Nov"},{"issue":"1","key":"1219_CR127","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1093\/rheumatology\/keac269","volume":"23","author":"W Zhang","year":"2022","unstructured":"Zhang W, Zheng Y, Wang Y, et al. Thigh MRI in antisynthetase syndrome, and comparisons with dermatomyositis and immune-mediated necrotizing myopathy. Rheumatology (Oxford) Dec. 2022;23(1):310\u201320. https:\/\/doi.org\/10.1093\/rheumatology\/keac269.","journal-title":"Rheumatology (Oxford) Dec"},{"issue":"6","key":"1219_CR128","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.2214\/AJR.17.17849","volume":"209","author":"JB Guimaraes","year":"2017","unstructured":"Guimaraes JB, Zanoteli E, Link TM, et al. Sporadic Inclusion Body Myositis: MRI Findings and Correlation With Clinical and Functional Parameters. AJR Am J Roentgenol Dec. 2017;209(6):1340\u20137. https:\/\/doi.org\/10.2214\/AJR.17.17849.","journal-title":"AJR Am J Roentgenol Dec"},{"issue":"6","key":"1219_CR129","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/mus.24661","volume":"52","author":"G Tasca","year":"2015","unstructured":"Tasca G, Monforte M, De Fino C, Kley RA, Ricci E, Mirabella M. Magnetic resonance imaging pattern recognition in sporadic inclusion-body myositis. Muscle Nerve Dec. 2015;52(6):956\u201362. https:\/\/doi.org\/10.1002\/mus.24661.","journal-title":"Muscle Nerve Dec"},{"issue":"7","key":"1219_CR130","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1002\/acn3.50801","volume":"6","author":"AMS Silva","year":"2019","unstructured":"Silva AMS, Coimbra-Neto AR, Souza PVS, et al. Clinical and molecular findings in a cohort of ANO5-related myopathy. Ann Clin Transl Neurol Jul. 2019;6(7):1225\u201338. https:\/\/doi.org\/10.1002\/acn3.50801.","journal-title":"Ann Clin Transl Neurol Jul"},{"issue":"1","key":"1219_CR131","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00415-019-09539-y","volume":"267","author":"A Barp","year":"2020","unstructured":"Barp A, Laforet P, Bello L, et al. European muscle MRI study in limb girdle muscular dystrophy type R1\/2A (LGMDR1\/LGMD2A). J Neurol Jan. 2020;267(1):45\u201356. https:\/\/doi.org\/10.1007\/s00415-019-09539-y.","journal-title":"J Neurol Jan"},{"issue":"8","key":"1219_CR132","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.nmd.2011.04.010","volume":"21","author":"H Komaki","year":"2011","unstructured":"Komaki H, Hayashi YK, Tsuburaya R, et al. Inflammatory changes in infantile-onset LMNA-associated myopathy. Neuromuscul Disord Aug. 2011;21(8):563\u20138. https:\/\/doi.org\/10.1016\/j.nmd.2011.04.010.","journal-title":"Neuromuscul Disord Aug"},{"issue":"6","key":"1219_CR133","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.3899\/jrheum.140554","volume":"42","author":"E Moraitis","year":"2015","unstructured":"Moraitis E, Foley AR, Pilkington CA, et al. Infantile-onset -associated Muscular Dystrophy Mimicking Juvenile Idiopathic Inflammatory Myopathy. Journal Rheumatology Jun. 2015;42(6):1064\u20136. https:\/\/doi.org\/10.3899\/jrheum.140554.","journal-title":"Journal Rheumatology Jun"},{"issue":"8","key":"1219_CR134","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1001\/archneur.64.8.1176","volume":"64","author":"K Nguyen","year":"2007","unstructured":"Nguyen K, Bassez G, Krahn M, et al. Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes. Arch Neurol Aug. 2007;64(8):1176\u201382. https:\/\/doi.org\/10.1001\/archneur.64.8.1176.","journal-title":"Arch Neurol Aug"},{"issue":"4","key":"1219_CR135","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1212\/WNL.0b013e3181ea1564","volume":"27","author":"C Paradas","year":"2010","unstructured":"Paradas C, Llauger J, Diaz-Manera J, et al. Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studies. Neurology Jul. 2010;27(4):316\u201323. https:\/\/doi.org\/10.1212\/WNL.0b013e3181ea1564.","journal-title":"Neurology Jul"},{"issue":"10","key":"1219_CR136","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1136\/jnnp-2017-317488","volume":"89","author":"J Diaz-Manera","year":"2018","unstructured":"Diaz-Manera J, Fernandez-Torron R, J LL, et al. Muscle MRI in patients with dysferlinopathy: pattern recognition and implications for clinical trials. J Neurol Neurosurg Psychiatry Oct. 2018;89(10):1071\u201381. https:\/\/doi.org\/10.1136\/jnnp-2017-317488.","journal-title":"J Neurol Neurosurg Psychiatry Oct"},{"key":"1219_CR137","unstructured":"Darras BT, Urion DK, Ghosh PS. Dystrophinopathies. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, eds. GeneReviews((R)). 1993."},{"issue":"10","key":"1219_CR138","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1093\/rheumatology\/kem196","volume":"46","author":"KP Ng","year":"2007","unstructured":"Ng KP, Smith CR, Isenberg DA. Muscular dystrophy mimicking refractory idiopathic inflammatory myositis: a trio of cases. Rheumatology (Oxford) Oct. 2007;46(10):1618\u20139. https:\/\/doi.org\/10.1093\/rheumatology\/kem196.","journal-title":"Rheumatology (Oxford) Oct"},{"issue":"4","key":"1219_CR139","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3346\/jkms.2011.26.4.587","volume":"26","author":"J Yoon","year":"2011","unstructured":"Yoon J, Kim SH, Ki CS, et al. Carrier woman of Duchenne muscular dystrophy mimicking inflammatory myositis. J Korean Med Sci Apr. 2011;26(4):587\u201391. https:\/\/doi.org\/10.3346\/jkms.2011.26.4.587.","journal-title":"J Korean Med Sci Apr"},{"issue":"4","key":"1219_CR140","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/mus.24621","volume":"52","author":"JM Statland","year":"2015","unstructured":"Statland JM, Shah B, Henderson D, Van Der Maarel S, Tapscott SJ, Tawil R. Muscle pathology grade for facioscapulohumeral muscular dystrophy biopsies. Muscle Nerve Oct. 2015;52(4):521\u20136. https:\/\/doi.org\/10.1002\/mus.24621.","journal-title":"Muscle Nerve Oct"},{"issue":"4","key":"1219_CR141","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s13311-018-00675-3","volume":"15","author":"J Hamel","year":"2018","unstructured":"Hamel J, Tawil R. Facioscapulohumeral Muscular Dystrophy: Update on Pathogenesis and Future Treatments. Neurotherapeutics Oct. 2018;15(4):863\u201371. https:\/\/doi.org\/10.1007\/s13311-018-00675-3.","journal-title":"Neurotherapeutics Oct"},{"issue":"10","key":"1219_CR142","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.neurol.2016.08.002","volume":"172","author":"F Fatehi","year":"2016","unstructured":"Fatehi F, Salort-Campana E, Le Troter A, Bendahan D, Attarian S. Muscle MRI of facioscapulohumeral dystrophy (FSHD): A growing demand and a promising approach. Rev Neurol (Paris) Oct. 2016;172(10):566\u201371. https:\/\/doi.org\/10.1016\/j.neurol.2016.08.002.","journal-title":"Rev Neurol (Paris) Oct"},{"issue":"5","key":"1219_CR143","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s00415-005-0684-4","volume":"252","author":"D Fischer","year":"2005","unstructured":"Fischer D, Walter MC, Kesper K, et al. Diagnostic value of muscle MRI in differentiating LGMD2I from other LGMDs. J Neurol May. 2005;252(5):538\u201347. https:\/\/doi.org\/10.1007\/s00415-005-0684-4.","journal-title":"J Neurol May"},{"key":"1219_CR144","doi-asserted-by":"crossref","unstructured":"Lacomis D. Making the Diagnosis of Myositis: Electrodiagnostic Testing. In: Agarwal R, Oddis CV, editors. Managing myositis. Springer Nature; 2019. pp. 99\u2013108.","DOI":"10.1007\/978-3-030-15820-0_12"},{"issue":"1","key":"1219_CR145","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.pmr.2012.08.017","volume":"24","author":"S Paganoni","year":"2013","unstructured":"Paganoni S, Amato A. Electrodiagnostic evaluation of myopathies. Phys Med Rehabil Clin N Am Feb. 2013;24(1):193\u2013207. https:\/\/doi.org\/10.1016\/j.pmr.2012.08.017.","journal-title":"Phys Med Rehabil Clin N Am Feb"},{"issue":"3","key":"1219_CR146","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/mus.26381","volume":"59","author":"U Sener","year":"2019","unstructured":"Sener U, Martinez-Thompson J, Laughlin RS, Dimberg EL, Rubin DI. Needle electromyography and histopathologic correlation in myopathies. Muscle Nerve Mar. 2019;59(3):315\u201320. https:\/\/doi.org\/10.1002\/mus.26381.","journal-title":"Muscle Nerve Mar"},{"key":"1219_CR147","doi-asserted-by":"crossref","unstructured":"Liewluck T. Electrodiagnostic assessment of myopathies. In: Rubin DI, editor. Clinical Neurophysiology (Contemporary Neurology Seriese). Oxford University Press; 2021.","DOI":"10.1093\/med\/9780190067854.003.0035"},{"issue":"2","key":"1219_CR148","doi-asserted-by":"publisher","first-page":"fcaa191","DOI":"10.1093\/braincomms\/fcaa191","volume":"2","author":"JD Triplett","year":"2020","unstructured":"Triplett JD, Shelly S, Livne G, et al. Diagnostic modelling and therapeutic monitoring of immune-mediated necrotizing myopathy: role of electrical myotonia. Brain Commun. 2020;2(2):fcaa191. https:\/\/doi.org\/10.1093\/braincomms\/fcaa191.","journal-title":"Brain Commun"},{"issue":"7","key":"1219_CR149","doi-asserted-by":"publisher","first-page":"e739","DOI":"10.1212\/WNL.0000000000013176","volume":"15","author":"J Tanboon","year":"2022","unstructured":"Tanboon J, Inoue M, Saito Y, et al. Dermatomyositis: Muscle Pathology According to Antibody Subtypes. Neurology Feb. 2022;15(7):e739\u201349. https:\/\/doi.org\/10.1212\/WNL.0000000000013176.","journal-title":"Neurology Feb"},{"issue":"4","key":"1219_CR150","doi-asserted-by":"publisher","first-page":"e13155","DOI":"10.1111\/bpa.13155","volume":"33","author":"J Tanboon","year":"2023","unstructured":"Tanboon J, Inoue M, Hirakawa S, et al. Muscle pathology of antisynthetase syndrome according to antibody subtypes. Brain Pathol Jul. 2023;33(4):e13155. https:\/\/doi.org\/10.1111\/bpa.13155.","journal-title":"Brain Pathol Jul"},{"issue":"5","key":"1219_CR151","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1212\/WNL.0000000000003568","volume":"31","author":"A Uruha","year":"2017","unstructured":"Uruha A, Nishikawa A, Tsuburaya RS, et al. Sarcoplasmic MxA expression: A valuable marker of dermatomyositis. Neurology Jan. 2017;31(5):493\u2013500. https:\/\/doi.org\/10.1212\/WNL.0000000000003568.","journal-title":"Neurology Jan"},{"issue":"3","key":"1219_CR152","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/0046-8177(89)90128-7","volume":"20","author":"AM Emslie-Smith","year":"1989","unstructured":"Emslie-Smith AM, Arahata K, Engel AG. Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum Pathol Mar. 1989;20(3):224\u201331. https:\/\/doi.org\/10.1016\/0046-8177(89)90128-7.","journal-title":"Hum Pathol Mar"},{"key":"1219_CR153","doi-asserted-by":"crossref","unstructured":"Arahata K, Ishihara T, Fukunaga H et al. Inflammatory response in facioscapulohumeral muscular dystrophy (FSHD): immunocytochemical and genetic analyses. Muscle Nerve Suppl. 1995; 2 :S56\u201366.","DOI":"10.1002\/mus.880181312"},{"issue":"1\u20132","key":"1219_CR154","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/s0165-5728(03)00255-8","volume":"142","author":"P Confalonieri","year":"2003","unstructured":"Confalonieri P, Oliva L, Andreetta F, et al. Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: an immunopathological study. J Neuroimmunol Sep. 2003;142(1\u20132):130\u20136. https:\/\/doi.org\/10.1016\/s0165-5728(03)00255-8.","journal-title":"J Neuroimmunol Sep"},{"issue":"2","key":"1219_CR155","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10875-010-9474-6","volume":"31","author":"G Frisullo","year":"2011","unstructured":"Frisullo G, Frusciante R, Nociti V, et al. CD8(+) T cells in facioscapulohumeral muscular dystrophy patients with inflammatory features at muscle MRI. J Clin Immunol Apr. 2011;31(2):155\u201366. https:\/\/doi.org\/10.1007\/s10875-010-9474-6.","journal-title":"J Clin Immunol Apr"},{"issue":"4","key":"1219_CR156","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/acn3.51751","volume":"10","author":"P Chompoopong","year":"2023","unstructured":"Chompoopong P, Oskarsson B, Madigan NN, et al. Multisystem proteinopathies (MSPs) and MSP-like disorders: Clinical-pathological-molecular spectrum. Ann Clin Transl Neurol Apr. 2023;10(4):632\u201343. https:\/\/doi.org\/10.1002\/acn3.51751.","journal-title":"Ann Clin Transl Neurol Apr"},{"issue":"5","key":"1219_CR157","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/WCO.0000000000001397","volume":"1","author":"M Inoue","year":"2025","unstructured":"Inoue M, Weihl CC. Myofibrillar myopathy: towards a mechanism-based definition as a Z-disk-opathy. Curr Opin Neurol Oct. 2025;1(5):513\u201323. https:\/\/doi.org\/10.1097\/WCO.0000000000001397.","journal-title":"Curr Opin Neurol Oct"},{"issue":"3","key":"1219_CR158","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1212\/01.wnl.0000061520.63546.8f","volume":"12","author":"I Yabe","year":"2003","unstructured":"Yabe I, Higashi T, Kikuchi S, et al. GNE mutations causing distal myopathy with rimmed vacuoles with inflammation. Neurology Aug. 2003;12(3):384\u20136. https:\/\/doi.org\/10.1212\/01.wnl.0000061520.63546.8f.","journal-title":"Neurology Aug"},{"issue":"4","key":"1219_CR159","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.nmd.2014.12.009","volume":"25","author":"CC Weihl","year":"2015","unstructured":"Weihl CC, Baloh RH, Lee Y, et al. Targeted sequencing and identification of genetic variants in sporadic inclusion body myositis. Neuromuscul Disord Apr. 2015;25(4):289\u201396. https:\/\/doi.org\/10.1016\/j.nmd.2014.12.009.","journal-title":"Neuromuscul Disord Apr"},{"issue":"1","key":"1219_CR160","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000360730","volume":"6","author":"J Tanboon","year":"2014","unstructured":"Tanboon J, Rongsa K, Pithukpakorn M, Boonyapisit K, Limwongse C, Sangruchi T. A Novel Mutation of the GNE Gene in Distal Myopathy with Rimmed Vacuoles: A Case with Inflammation. Case Rep Neurol Jan. 2014;6(1):55\u20139. https:\/\/doi.org\/10.1159\/000360730.","journal-title":"Case Rep Neurol Jan"},{"issue":"10","key":"1219_CR161","doi-asserted-by":"publisher","first-page":"e214255","DOI":"10.1212\/WNL.0000000000214255","volume":"25","author":"T Wannarong","year":"2025","unstructured":"Wannarong T, Milone M, Selcen D, Dyck PJB, Liewluck T. Natural History and Phenotypic Spectrum of Myofibrillar Myopathies and Myopathies Associated With MFM-Related Genes. Neurology Nov. 2025;25(10):e214255. https:\/\/doi.org\/10.1212\/WNL.0000000000214255.","journal-title":"Neurology Nov"},{"issue":"1","key":"1219_CR162","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00401-023-02669-8","volume":"12","author":"C Nelke","year":"2024","unstructured":"Nelke C, Schmid S, Kleefeld F, et al. Complement and MHC patterns can provide the diagnostic framework for inflammatory neuromuscular diseases. Acta Neuropathol Jan. 2024;12(1):15. https:\/\/doi.org\/10.1007\/s00401-023-02669-8.","journal-title":"Acta Neuropathol Jan"},{"issue":"12","key":"1219_CR163","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1093\/jnen\/nlae098","volume":"1","author":"LER Lessard","year":"2024","unstructured":"Lessard LER, Robert M, Fenouil T, et al. Contribution of major histocompatibility complex class II immunostaining in distinguishing idiopathic inflammatory myopathy subgroups: A histopathological cohort study. J Neuropathol Exp Neurol Dec. 2024;1(12):1060\u201375. https:\/\/doi.org\/10.1093\/jnen\/nlae098.","journal-title":"J Neuropathol Exp Neurol Dec"},{"issue":"2","key":"1219_CR164","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/bpa.12772","volume":"30","author":"N Fischer","year":"2020","unstructured":"Fischer N, Preusse C, Radke J, et al. Sequestosome-1 (p62) expression reveals chaperone-assisted selective autophagy in immune-mediated necrotizing myopathies. Brain Pathol Mar. 2020;30(2):261\u201371. https:\/\/doi.org\/10.1111\/bpa.12772.","journal-title":"Brain Pathol Mar"},{"issue":"1","key":"1219_CR165","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/mus.27739","volume":"67","author":"IJ Acosta","year":"2023","unstructured":"Acosta IJ, Stenzel W, Hofer M, Brady S. Autophagy in non-immune-mediated rhabdomyolysis: Assessment of p62 immunohistochemistry. Muscle Nerve Jan. 2023;67(1):73\u20137. https:\/\/doi.org\/10.1002\/mus.27739.","journal-title":"Muscle Nerve Jan"},{"issue":"10","key":"1219_CR166","doi-asserted-by":"publisher","first-page":"e210001","DOI":"10.1212\/WNL.0000000000210001","volume":"26","author":"AR Santilli","year":"2024","unstructured":"Santilli AR, Ni O, Milone M, et al. Immune-Mediated Megaconial Myopathy: A Novel Subtype of Autoimmune Myopathy. Neurology Nov. 2024;26(10):e210001. https:\/\/doi.org\/10.1212\/WNL.0000000000210001.","journal-title":"Neurology Nov"},{"issue":"7","key":"1219_CR167","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1212\/WNL.0000000000007952","volume":"13","author":"NN Madigan","year":"2019","unstructured":"Madigan NN, Liewluck T, Milone M, Naddaf E. Necrotizing autoimmune myopathy with tubular aggregates. Neurology Aug. 2019;13(7):313\u20134. https:\/\/doi.org\/10.1212\/WNL.0000000000007952.","journal-title":"Neurology Aug"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-026-01219-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-026-01219-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-026-01219-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T07:39:53Z","timestamp":1778485193000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-026-01219-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":167,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1219"],"URL":"https:\/\/doi.org\/10.1007\/s11926-026-01219-x","relation":{},"ISSN":["1534-6307"],"issn-type":[{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}